Literature DB >> 35848189

[Advances of the role of mitochondrial dysfunction in the spinal cord injury and its relevant treatments].

Xin Miao1, Junqing Lin1, Xianyou Zheng1.   

Abstract

Objective: To review the advances of the role of mitochondrial dysfunction in the spinal cord injury (SCI) and its relevant treatments.
Methods: Focusing on various mechanisms of mitochondrial dysfunction, recent relevant literature at home and abroad was identified to summarize the therapeutic strategies for SCI.
Results: Mitochondrial dysfunction is mainly manifested in abnormalities in mitochondrial energy metabolism, mitochondrial oxidative stress, mitochondrial-mediated apoptosis, mitophagy, mitochondrial permeability transition, and mitochondrial biogenesis, playing a vital role in the development of SCI. Drug that enhanced mitochondrial function have been proved beneficial for the treatment of SCI.
Conclusion: Mitochondrial dysfunction can serve as a potential therapeutic target for SCI, providing ideas and basis for the development of SCI therapeutic candidates in the future.

Entities:  

Keywords:  Spinal cord injury; mitochondrial dysfunction; therapeutic strategies

Mesh:

Year:  2022        PMID: 35848189      PMCID: PMC9288914          DOI: 10.7507/1002-1892.202203081

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  44 in total

Review 1.  Transplanting neural progenitor cells to restore connectivity after spinal cord injury.

Authors:  Itzhak Fischer; Jennifer N Dulin; Michael A Lane
Journal:  Nat Rev Neurosci       Date:  2020-06-09       Impact factor: 34.870

Review 2.  Targeting apoptosis and autophagy following spinal cord injury: Therapeutic approaches to polyphenols and candidate phytochemicals.

Authors:  Fatemeh Abbaszadeh; Sajad Fakhri; Haroon Khan
Journal:  Pharmacol Res       Date:  2020-07-08       Impact factor: 7.658

Review 3.  Mitochondria focused neurotherapeutics for spinal cord injury.

Authors:  Alexander G Rabchevsky; Felicia M Michael; Samir P Patel
Journal:  Exp Neurol       Date:  2020-04-27       Impact factor: 5.620

4.  The Neuroprotective Effect of Tetramethylpyrazine Against Contusive Spinal Cord Injury by Activating PGC-1α in Rats.

Authors:  Jianzhong Hu; Ye Lang; Yong Cao; Tao Zhang; Hongbin Lu
Journal:  Neurochem Res       Date:  2015-05-16       Impact factor: 3.996

5.  Inhibition of cyclophilin D by cyclosporin A promotes retinal ganglion cell survival by preventing mitochondrial alteration in ischemic injury.

Authors:  S Y Kim; M S Shim; K-Y Kim; R N Weinreb; L A Wheeler; W-K Ju
Journal:  Cell Death Dis       Date:  2014-03-06       Impact factor: 8.469

6.  Selenium-Doped Carbon Quantum Dots Efficiently Ameliorate Secondary Spinal Cord Injury via Scavenging Reactive Oxygen Species.

Authors:  Wenqi Luo; Yiming Wang; Feng Lin; Yixuan Liu; Rui Gu; Wanguo Liu; Chunsheng Xiao
Journal:  Int J Nanomedicine       Date:  2020-12-14

Review 7.  Sirtuins: Potential Therapeutic Targets for Defense against Oxidative Stress in Spinal Cord Injury.

Authors:  Jialiang Lin; Zhencheng Xiong; Jionghui Gu; Zhuoran Sun; Shuai Jiang; Dongwei Fan; Weishi Li
Journal:  Oxid Med Cell Longev       Date:  2021-06-24       Impact factor: 6.543

8.  Functional Recovery of Contused Spinal Cord in Rat with the Injection of Optimal-Dosed Cerium Oxide Nanoparticles.

Authors:  Jong-Wan Kim; Chinmaya Mahapatra; Jin-Young Hong; Min Soo Kim; Kam W Leong; Hae-Won Kim; Jung Keun Hyun
Journal:  Adv Sci (Weinh)       Date:  2017-07-08       Impact factor: 16.806

Review 9.  Delving into the recent advancements of spinal cord injury treatment: a review of recent progress.

Authors:  Joseph A Flack; Krishna Deo Sharma; Jennifer Yanhua Xie
Journal:  Neural Regen Res       Date:  2022-02       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.